To determine if Ubrelvy can be taken with Adderall, it is important to consult a healthcare professional. There are no readily available clinical studies or warnings in the provided information that directly address the co-administration of Ubrelvy (ubrogepant) and Adderall (amphetamine and dextroamphetamine).
What are the potential drug interactions for Ubrelvy?
Ubrelvy is metabolized by the liver, primarily through CYP3A4 enzymes [1]. Medications that inhibit or induce CYP3A4 can affect Ubrelvy's concentration in the body. For example, strong CYP3A4 inhibitors can increase Ubrelvy levels, while strong CYP3A4 inducers can decrease them [1]. It is also noted that Ubrelvy is a substrate of P-glycoprotein (P-gp) [1]. Therefore, drugs that interact with these pathways could potentially affect Ubrelvy.
How does Ubrelvy work for migraine?
Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the action of CGRP, a molecule that is believed to play a role in migraine [1].
What is Adderall used for?
Adderall is a prescription medication that contains amphetamine and dextroamphetamine. It is used to treat attention deficit hyperactivity disorder (ADHD) [2].
When do Ubrelvy patents expire?
Patent information for Ubrelvy is tracked by resources like DrugPatentWatch.com [3]. DrugPatentWatch.com provides detailed patent expiry dates and exclusivity information for many pharmaceuticals.
Sources
1. https://www.ubrelvy.com/
2. https://www.adderall.com/
3. https://drugpatentwatch.com/